Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Boehringer Ingelheim
Express Scripts
McKinsey
Merck

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR INSULATARD NPH HUMAN

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for Insulatard Nph Human

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00346996 ↗ Insulin Analogues and Severe Hypoglycaemia Completed Novo Nordisk A/S Phase 4 2007-05-01 Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00346996 ↗ Insulin Analogues and Severe Hypoglycaemia Completed Lise Tarnow Phase 4 2007-05-01 Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00566124 ↗ Basal Insulins - Pharmacodynamics Completed Novo Nordisk A/S Phase 4 2005-01-01 To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00566124 ↗ Basal Insulins - Pharmacodynamics Completed The Danish Diabetes Association Phase 4 2005-01-01 To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Insulatard Nph Human

Condition Name

Condition Name for Insulatard Nph Human
Intervention Trials
Diabetes 7
Diabetes Mellitus, Type 2 4
Type 1 Diabetes 2
Diabetes Mellitus, Type 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Insulatard Nph Human
Intervention Trials
Diabetes Mellitus 8
Diabetes Mellitus, Type 2 6
Diabetes Mellitus, Type 1 4
Hyperglycemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Insulatard Nph Human

Trials by Country

Trials by Country for Insulatard Nph Human
Location Trials
Denmark 3
Germany 2
Romania 1
Austria 1
Hungary 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Insulatard Nph Human

Clinical Trial Phase

Clinical Trial Phase for Insulatard Nph Human
Clinical Trial Phase Trials
Phase 4 5
Phase 2 1
Phase 1 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Insulatard Nph Human
Clinical Trial Phase Trials
Completed 11
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Insulatard Nph Human

Sponsor Name

Sponsor Name for Insulatard Nph Human
Sponsor Trials
Novo Nordisk A/S 8
The Danish Diabetes Association 1
The Institute of Experimental Clinical Research, University of Aarhus 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Insulatard Nph Human
Sponsor Trials
Other 10
Industry 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Dow
AstraZeneca
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.